Position in VTRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13,154,927
-$1,814,232 QoQ
Shares Held
828,396
-25.2% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#105
of 1,020 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $480,515,408 across 25 Drug Manufacturers - Specialty & Generic names. VTRS ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
1,494,259 | $251,842,409 | |
| 2 | ZTS |
Zoetis Inc.
|
1,173,974 | $84,361,770 | |
| 3 | ALKS |
Alkermes plc.
|
1,159,216 | $60,742,916 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
976,103 | $33,070,368 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
44,851 | $24,301,615 | |
| 6 | VTRS |
Viatris Inc
This page
|
828,396 | $13,154,927 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
94,458 | $3,875,610 | |
| 8 | PBH |
Prestige Consumer Healthcare Inc.
|
72,383 | $3,421,543 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,154,927 | 828,396 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $14,969,159 | 1,108,006 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $19,414,081 | 1,559,364 | Shares | Defined | 2026-02-13 | |
| 2025-06-30 | $414,378 | 46,403 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $1,418,606 | 162,871 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,043,244 | 164,116 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,510,867 | 130,135 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $2,239,900 | 210,715 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $1,499,568 | 125,592 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $2,090,601 | 193,038 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,809,033 | 183,472 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,583,536 | 158,671 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $2,094,918 | 217,767 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $2,454,665 | 220,545 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,094,378 | 363,190 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $600,600 | 57,364 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $558,448 | 51,328 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,064,716 | 78,693 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $980,938 | 72,394 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $1,102,815 | 77,174 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $369,073 | 26,419 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $576,760 | 30,777 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||